Literature DB >> 11679055

Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm.

H Houshyar1, Z D Cooper, J H Woods.   

Abstract

Body temperature and pituitary-adrenal responses to restraint (15 min or 4 h) stress were evaluated in nondependent and morphine-dependent rats. Male Sprague-Dawley rats were treated twice daily with increasing doses of morphine (10-100 mg/kg, s.c.) for 16 days. Transmitters were implanted in the peritoneal cavity to monitor body temperature and blood was collected for hormone assays. Acute withdrawal from chronic morphine treatment was associated with reduced body weight, increased adrenal weight and decreased thymus weight. Sixteen days after termination of chronic morphine treatment, rats had recovered normal adrenal size, but still displayed marked thymus involution and reduced body weight. Restraint-induced hyperthermia was attenuated in morphine-dependent rats that had undergone 12-h withdrawal. Sixteen days after withdrawal, rats still had not fully recovered the hyperthermic response to restraint. Chronic morphine treatment resulted in a marked elevation of basal corticosterone concentrations. Despite the negative-feedback effects of elevated basal corticosterone concentrations, morphine-dependent rats that had undergone 12-h withdrawal displayed a potentiated and prolonged corticosterone response to restraint stress. In contrast, rats that had undergone 8-day and 16-day morphine withdrawal had recovered normal basal pituitary-adrenal activity, but displayed significantly reduced and shorter adrenocorticotropic hormone and corticosterone responses to restraint. These results suggest that chronic morphine dependence is a chronic stressor, resulting in profound and long-lasting changes in the temperature and pituitary-adrenal responses to acute restraint stress in a time-dependent manner. This morphine-dependence model may be useful in understanding the role that hormonal stress responses play in the maintenance and relapse to opioid use in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679055     DOI: 10.1046/j.1365-2826.2001.00713.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  13 in total

1.  Hypoactivity of the hypothalamo-pituitary-adrenocortical axis during recovery from chronic variable stress.

Authors:  Michelle M Ostrander; Yvonne M Ulrich-Lai; Dennis C Choi; Neil M Richtand; James P Herman
Journal:  Endocrinology       Date:  2006-01-05       Impact factor: 4.736

2.  Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus.

Authors:  J W Lunden; L G Kirby
Journal:  Neuroscience       Date:  2013-09-20       Impact factor: 3.590

3.  Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006.

Authors:  Amy S B Bohnert; Marta R Prescott; David Vlahov; Kenneth J Tardiff; Sandro Galea
Journal:  Addiction       Date:  2010-03-02       Impact factor: 6.526

4.  Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.

Authors:  Emily M Jutkiewicz; Mary M Torregrossa; Katarzyna Sobczyk-Kojiro; Henry I Mosberg; John E Folk; Kenner C Rice; Stanley J Watson; James H Woods
Journal:  Eur J Pharmacol       Date:  2006-01-25       Impact factor: 4.432

Review 5.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

6.  Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers.

Authors:  Nathalie V Goletiani; Jack H Mendelson; Michelle B Sholar; Arthur J Siegel; Alicja Skupny; Nancy K Mello
Journal:  Pharmacol Biochem Behav       Date:  2007-02-20       Impact factor: 3.533

7.  Concurrent and longitudinal associations between diurnal cortisol and body mass index across adolescence.

Authors:  Paula L Ruttle; Kristin N Javaras; Marjorie H Klein; Jeffrey M Armstrong; Linnea R Burk; Marilyn J Essex
Journal:  J Adolesc Health       Date:  2013-02-08       Impact factor: 5.012

8.  Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat.

Authors:  Ziva D Cooper; Yen Nhu-Thi Truong; Yong-Gong Shi; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2008-05-30       Impact factor: 4.030

Review 9.  Targeting the mu-Opioid Receptor for Cancer Treatment.

Authors:  Hao Zhang; Di Zhou; Jiahui Gu; Mengdi Qu; Kefang Guo; Wankun Chen; Changhong Miao
Journal:  Curr Oncol Rep       Date:  2021-08-03       Impact factor: 5.075

10.  Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.

Authors:  Jeffrey L Voorhees; Andrew J Tarr; Eric S Wohleb; Jonathan P Godbout; Xiaokui Mo; John F Sheridan; Timothy D Eubank; Clay B Marsh
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.